Cardiotoxicity is one of the major safety concerns in the use of
drug and is the most common reason for
drug removal from the market. At present, several drugs that have been recognized as the clinically effective
drug have been reported to be associated with a high risk of
cardiotoxicity during clinical use. The most representative ones are
doxorubicin,
arsenic trioxide,
isoproterenol,
cyclophosphamide, etc. The adverse effects seriously affect the human health and limit the clinical application of the drugs mentioned above. Over the past years, many strategies have been carried out to prevent the occurrence of
drug-induced
cardiotoxicity, including early detection of
cardiotoxicity by
biomarkers, limitation of doses, changing of
drug-delivery way, combining with
cardioprotective agent. Among them, combining with
cardioprotective agent has gained increased interest and has been considered as a promising approach for continued treatment. Therefore, looking for effective
cardioprotective agent to avoid the occurrence of
drug-induced
cardiotoxicity has become a great challenge for many researchers. Interestingly, some phenolic
acids compounds from natural plants have been demonstrated to establish a significant protective effect in
drug-induced
cardiotoxicity. In this work, we reviewed the cardioprotective potentials and the involved mechanisms of phenolic
acids in
drug-induced
cardiotoxicity. To provide a reference for the further application of phenolic
acids in the prevention of
drug-induced
cardiotoxicity.